Found: 7
Select item for more details and to access through your institution.
Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants.
- Published in:
- Advanced Science, 2022, v. 9, n. 11, p. 1, doi. 10.1002/advs.202105378
- By:
- Publication type:
- Article
Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05159-x
- By:
- Publication type:
- Article
Brd4 Regulates the Homeostasis of CD8<sup>+</sup> T-Lymphocytes and Their Proliferation in Response to Antigen Stimulation.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.728082
- By:
- Publication type:
- Article
Correlation between circulating T follicular helper cell levels after infection and a decreased risk of COVID-19 re-infection.
- Published in:
- Virologica Sinica (16740769), 2024, v. 39, n. 4, p. 699, doi. 10.1016/j.virs.2024.06.002
- By:
- Publication type:
- Article
Antibody response and cross-neutralization after Omicron BA.2 infection.
- Published in:
- 2023
- By:
- Publication type:
- Letter
SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance.
- Published in:
- 2021
- By:
- Publication type:
- Letter
The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry.
- Published in:
- Signal Transduction & Targeted Therapy, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41392-021-00604-5
- By:
- Publication type:
- Article